A new pharmacological treatment for myocardial damage and arrhythmias arising from hypoxia, ischaemia or reperfusion
Despite successful education campaigns through the media, and the evolution of numerous treatments, ischaemic heart disease remains one of the biggest causes of morbidity and mortality in the Western World. Development of anti-arrhythmic drugs was largely halted in the late'80s and early '90s prior to the discovery of the myocardial persistent sodium current and in particular, prior to the discovery that the myocardial persistent sodium current is considerably enhanced by hypoxia. We...[Show more]
|Collections||Open Access Theses|
|Access Rights:||Open Access|
|b25698606_Weiss_Steven Michael.pdf||54.54 MB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.